SUPPRESSION OF INSULITIS IN NONOBESE DIABETIC (NOD) MICE BY ORAL INSULIN ADMINISTRATION IS ASSOCIATED WITH SELECTIVE EXPRESSION OF INTERLEUKIN-4 AND INTERLEUKIN-10, TRANSFORMING GROWTH-FACTOR-BETA, AND PROSTAGLANDIN-E

被引:0
|
作者
HANCOCK, WW
POLANSKI, M
ZHANG, J
BLOGG, N
WEINER, HL
机构
[1] NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
[2] HARVARD UNIV,SCH MED,BOSTON,MA
[3] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,CTR NEUROL DIS,DEPT MED,BOSTON,MA 02115
来源
AMERICAN JOURNAL OF PATHOLOGY | 1995年 / 147卷 / 05期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Oral administration of autoantigens suppresses development of autoimmunity in several animal models, and is being tested in clinical trials in patients with autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. Non-obese diabetic (NOD) mice spontaneously develop insulin-dependent diabetes mellitus at 15 to 20 weeks of age, after mononuclear cell (MNC) infiltration of the pancreatic islets of Langerhans and destruction of insulin-producing beta cells. We have previously shown that oral administration of insulin suppresses insulitis and development of diabetes in the NOD mouse. Oral insulin has metabolic effect on blood glucose. Oral insulin mediates its effect through a T cell-dependent mechanism as shown by adoptive transfer and T cell depletion experiments, but the mechanisms responsible have not been fully explored. We now report a serial analysis of the cells and cytokines associated with development of diabetes in NOD mice, and contrast this with the finding of diabetes in NOD mice, and contrast this with the findings in animals fed equine insulin or a control protein (ovalbumin). Animals were fed 1 mg twice a week for 5 weeks, beginning at 5 weeks of age. Marked insulitis in naive or ovalbumin-fed NOD mice occurred at 10 weeks, at which time a dense peri-islet and intra-islet MNC infiltration was observed. Immunohistological studies using monoclonal antibodies showed that infiltrating MNC consisted mainly of CD4(+) T cells (>75% of leukocytes) plus smaller numbers of macrophages and CD8(+) T cells, These cells displayed evidence of immune activation with expression of receptors for interleukin-2 (IL-2R) plus Tb1 cytokines; dense labeling for IFN-gamma and tumor necrosis factor-alpha, plus lesser amounts of IL-2, was observed. MNC lacked labeling for IL-4, IL-10, prostaglandin-E, or transforming growth factor-beta. By contrast, at 10 weeks, pancreatic tissues from NOD mice fed insulin showed considerably less insulitis, and the residual MNC, although still largely CD4(+) T cells plus macrophages, showed dense labeling for IL-4, IL-10, prostaglandin-E, and transforming growth factor-beta and an absence of IL-2, IFN-gamma or tumor necrosis factor-alpha. Taken together with our previous findings, these data indicate that oral administration of insulin affects the development of diabetes in NOD mice through the generation of cells that elaborate immunoregulatory cytokines within the target organ and shift the balance from a Tb1 to a Tb2 pattern of cytokine expression.
引用
收藏
页码:1193 / 1199
页数:7
相关论文
共 29 条
  • [1] MODULATION OF MACROPHAGE FUNCTION BY TRANSFORMING GROWTH-FACTOR-BETA, INTERLEUKIN-4, AND INTERLEUKIN-10
    BOGDAN, C
    NATHAN, C
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 685 : 713 - 739
  • [2] Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice
    Mueller, R
    Krahl, T
    Sarvetnick, N
    JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03): : 1093 - 1099
  • [3] SUPPRESSION OF MACROPHAGE CYTOKINE PRODUCTION BY TRANSFORMING GROWTH-FACTOR-BETA AND INTERLEUKIN-10
    BOGDAN, C
    PAIK, J
    BACH, EA
    VODOVOTZ, Y
    NATHAN, CF
    CLINICAL RESEARCH, 1992, 40 (02): : A198 - A198
  • [4] Gene polymorphisms of interleukin-4, interleukin-10 and transforming growth factor-beta in Graves' disease
    Khalilzadeh, Omid
    Anvari, Mehdi
    Momen-Heravi, Fatemeh
    Esteghamati, Alireza
    Rashidi, Armin
    Mahmoudi, Mahdi
    Nikbin, Behrouz
    Amirzargar, Aliakbar
    CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 10 (02) : 123 - 128
  • [5] Gene polymorphisms of interleukin-4, interleukin-10 and transforming growth factor-beta in Graves’ disease
    Omid Khalilzadeh
    Mehdi Anvari
    Fatemeh Momen-Heravi
    Alireza Esteghamati
    Armin Rashidi
    Mahdi Mahmoudi
    Behrouz Nikbin
    Aliakbar Amirzargar
    Clinical and Experimental Medicine, 2010, 10 : 123 - 128
  • [6] CONTRASTING MECHANISMS FOR SUPPRESSION OF MACROPHAGE CYTOKINE RELEASE BY TRANSFORMING GROWTH-FACTOR-BETA AND INTERLEUKIN-10
    BOGDAN, C
    PAIK, J
    VODOVOTZ, Y
    NATHAN, C
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (32) : 23301 - 23308
  • [7] TRANSFORMING GROWTH-FACTOR-BETA AND INTERLEUKIN-10, BUT NOT INTERLEUKIN-4, DOWN-REGULATE PROCOAGULANT ACTIVITY AND TISSUE FACTOR EXPRESSION IN HUMAN MONOCYTE-DERIVED MACROPHAGES
    JUNGI, TW
    BRCIC, M
    EPERON, S
    ALBRECHT, S
    THROMBOSIS RESEARCH, 1994, 76 (05) : 463 - 474
  • [8] Regulation of cytokine release by alveolar macrophages treated with interleukin-4, interleukin-10, or transforming growth factor beta
    Zissel, G
    Schlaak, J
    Schlaak, M
    MullerQuernheim, J
    EUROPEAN CYTOKINE NETWORK, 1996, 7 (01) : 59 - 66
  • [9] Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice
    Smith, DK
    Korbutt, GS
    SuarezPinzon, WL
    Kao, D
    Rajotte, RV
    Elliott, JF
    TRANSPLANTATION, 1997, 64 (07) : 1040 - 1049
  • [10] ORAL TOLERANCE TO MYELIN BASIC-PROTEIN AND NATURAL RECOVERY FROM EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS ARE ASSOCIATED WITH DOWN-REGULATION OF INFLAMMATORY CYTOKINES AND DIFFERENTIAL UP-REGULATION OF TRANSFORMING GROWTH-FACTOR-BETA, INTERLEUKIN-4, AND PROSTAGLANDIN-E EXPRESSION IN THE BRAIN
    KHOURY, SJ
    HANCOCK, WW
    WEINER, HL
    JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05): : 1355 - 1364